Drug Information

Drug General Information
Drug ID
D02FGF
Former ID
DNC011812
Drug Name
PO3 2-Nle-Trp-O-3K
Drug Type
Small molecular drug
Indication Discovery agent Investigative [551263]
Structure
Download
2D MOL

3D MOL
Formula
C17H21K3N3O6P
Canonical SMILES
CCCCC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)[O-])NP(=O)([O-])<br />[O-].[K+].[K+].[K+]
InChI
1S/C17H24N3O6P.3K/c1-2-3-7-14(20-27(24,25)26)16(21)19-15(17(22)23)9-11-10-18-13-8-5-4-6-12(11)13;;;/h4-6,8,10,14-15,18H,2-3,7,9H2,1H3,(H,19,21)(H,22,23)(H3,20,24,25,26);;;/q;3*+1/p-3/t14-,15-;;;/m0.../s1
InChIKey
NYVZQOLCRXDUOS-CEHYLXJWSA-K
PubChem Compound ID
44458230
Target and Pathway
Target(s) Endothelin-converting enzyme 1 Target Info Inhibitor [551263]
PANTHER Pathway Endothelin signaling pathway
WikiPathways SIDS Susceptibility Pathways
Corticotropin-releasing hormone
Endothelin Pathways
References
Ref 551263Aminophosphonate endothelin converting enzyme inhibitors: potency-enhancing and selectivity-improving modifications of phosphoramidon, Bioorg. Med. Chem. Lett. 4(10):1257-1262 (1994).
Ref 551263Aminophosphonate endothelin converting enzyme inhibitors: potency-enhancing and selectivity-improving modifications of phosphoramidon, Bioorg. Med. Chem. Lett. 4(10):1257-1262 (1994).

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.